Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
Open Access
- 1 April 2003
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 88 (7), 1091-1094
- https://doi.org/10.1038/sj.bjc.6600868
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Detection of circulating breast tumor cells by differential expression of marker genes.2002
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Cytokeratin-Positive Cells in the Bone Marrow and Survival of Patients with Stage I, II, or III Breast CancerNew England Journal of Medicine, 2000
- Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence–based amplification for the detection of circulating breast cancer cellsBreast Cancer Research and Treatment, 1999
- Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay.1999
- The detection of minimal numbers of contaminating epithelial tumor cells in blood or bone marrow: Use, limitations and future of RNA-based methodsAnnals Of Oncology, 1998
- Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.Journal of Clinical Oncology, 1997
- Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.1997
- High-sensitivity Detection of Minimal Residual Breast Carcinoma Using the Polymerase Chain Reaction and Primers for Cytokeratin 19Diagnostic Molecular Pathology, 1996
- Low specificity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination.Journal of Clinical Oncology, 1995